Potholes come with the territory in Greater Cleveland thanks to harsh winters and the freeze-thaw cycle that comes with it.
Neumora Therapeutics Inc.’s stock tumbled 81% Thursday after the clinical-stage biotech said a late-stage trial of a treatment for major depressive disorder failed to meet its main goals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback